November 20, 2025
OXFORD, UK and CLEVELAND, Ohio, US, 20 November 2025 – The Oxford-Harrington Rare Disease Centre (‘OHC’) today announced the recipients of the 2025 Rare Disease Scholar Award, which advances promising discoveries from academic labs into clinical practice. Each Scholar will receive an advisory team providing...
Continue Reading
July 11, 2024
University Hospitals and Case Western Reserve University team show cerebellum is a thirst-modulating brain center Continue Reading
May 17, 2024
The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership (between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio) aimed at driving cutting-edge rare disease breakthroughs, is pleased to announce that it has received a philanthropic donation of up to £650,000... Continue Reading
May 01, 2024
Unique program for physician-scientists to advance promising discoveries into medicines Continue Reading
April 16, 2024
10 physician-scientists have been selected for drug development grant to advance discoveries into the clinic Continue Reading
April 01, 2024
Call for proposals focused on proteostasis, senescence, and other novel approaches Continue Reading
March 25, 2024
Nature Chemical Biology, published March 25, 2024 Continue Reading
March 19, 2024
2024 Harrington Prize for Innovation in Medicine Recognizes Pioneering Work in Immunology Continue Reading
March 13, 2024
The rapidly evolving SARS-CoV-2 virus threatens the progress made in curbing the COVID-19 pandemic. A promising novel drug candidate, designed at the atomic level, could help doctors halt the rise of lethal new drug resistant variants. Continue Reading
February 08, 2024
Dr. Paul Tesar of Case Western Reserve University and Dr. Donald F. Weaver of University Health Network selected for their work targeting novel pathways in Alzheimer’s Continue Reading
February 06, 2024
New Scholar Award Accelerates Novel Therapies for Rare Diseases Continue Reading